Education To Prevent Abuse Reinforces DMX Safety As OTC – CHPA Study
This article was originally published in The Pink Sheet Daily
Executive Summary
Trade group's journal shows how its targeted campaign is likely influencing teens’ perceptions of DXM abuse.“Bait-and-switch” approach aims to educate teens looking online for information on how to abuse cough/cold OTC medications.
You may also be interested in...
HBW Market Roundup: Prop 65 Amendment Off, Enforcement Discretion Asked For Label Compliance, More
California withdraws Prop 65 proposal to clarify when and how average concentrations can be calculated for a listed chemical due to deadline; trade groups ask FDA for enforcement discretion on compliance date for Nutrition and Supplement Facts labels rules; FDA published list of necessary records for FSVP applications; and use of OTC analgesics grows in teen suicide attempts.
US Would Cough Up As Much As $31bn More For Rx-Only DXM Over 10 Years
A study the Consumer Healthcare Products Association commissioned finds OTC access to the cough suppressant dextromethorphan will save consumers between $22bn and $31bn through 2025 compared to a scenario of the product moving to Rx-only.
US Would Cough Up As Much As $31bn More For Rx-Only DXM Over 10 Years
A study the Consumer Healthcare Products Association commissioned finds OTC access to the cough suppressant dextromethorphan will save consumers between $22bn and $31bn through 2025 compared to a scenario of the product moving to Rx-only.